A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study.
about
A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A real-world risk analysis of ...... onwide population-based study.
@en
A real-world risk analysis of biological treatment
@nl
type
label
A real-world risk analysis of ...... onwide population-based study.
@en
A real-world risk analysis of biological treatment
@nl
prefLabel
A real-world risk analysis of ...... onwide population-based study.
@en
A real-world risk analysis of biological treatment
@nl
P2093
P2860
P1476
A real-world risk analysis of ...... onwide population-based study.
@en
P2093
P2860
P304
P356
10.1080/03009742.2016.1202318
P577
2016-10-21T00:00:00Z